arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Ardelyx, Inc.

ARDX Health Care Biotechnology: Pharmaceutical Preparations
$3.76
▼ -0.5% Today
as of Sep 4, 16:45 ET
Last 30 days -25.66% Jul 28 → Sep 04
$3.60 $4.00 $4.40 $4.80 $5.20 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$3.68
High
$3.78
Low
$3.68
Volume
$3M
Avg Vol
$4M
Mkt Cap
$974M
P/E (TTM)
Beta
52w High
$8.40
52w Low
$3.68
Div Yield
Shares Out
$249M

Recent Press Releases & News last 60 days · 15 items

▸ Show all 15 press releases & news Free account →

Overview

52-week range
$3.68
$8.40
2% of range
Avg surprise (last 2)
-15.8%
Avg reaction (last 1)
-0.6%
0% positive
Latest IV / EM
59%
EM ±9.3% · $4 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.17$-0.12$-0.07$-0.02$0.03 Actual $-0.13Actual $-0.08Actual $0.03Actual $-0.11Actual $-0.07Actual $-0.17Est $-0.10Actual $-0.08Est $-0.13Actual $-0.15Actual $-0.07 MarJunSepMarJunSepMar/2025Jun/2025SepMarJun
Revenue vs Net Income Revenue Net income
$-41M$872,212$43M$85M$127M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.07 financials
Tue Mar 31, 2026Mar 2026 $-0.15 financials
Tue Sep 30, 2025Sep 2025 financials
Mon Aug 4, 2025Jun/2025 $-0.08 $-0.13 +38.5% earnings
Thu May 1, 2025Mar/2025 $-0.17 $-0.10 -70.0% -0.6% earnings
Mon Sep 30, 2024Sep 2024 financials
Sun Jun 30, 2024Jun 2024 $-0.07 financials
Sun Mar 31, 2024Mar 2024 $-0.11 financials
Sat Sep 30, 2023Sep 2023 $0.03 financials
Fri Jun 30, 2023Jun 2023 $-0.08 financials
Fri Mar 31, 2023Mar 2023 $-0.13 financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$121M$94M$110M$98M$74M$98M
Cost of revenue$6M$5M$4M$12M$12M$16M
Gross profit
Operating income$-12M$-33M$5M$-14M$-36M$2M
Net income$-17M$-38M$-969,000$-19M$-41M$-809,000
EPS (diluted)$-0.07$-0.15$-0.08$-0.17

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$97M$31M$68M$43M$90M$31M$65M$47M
Inventory$139M$128M$123M$129M$123M$106M$91M$85M
Total current assets$442M$382M$382M$368M$352M$313M$356M$284M
Total assets$576M$505M$502M$486M$467M$410M$436M$368M
Long-term debt$252M$204M$203M$202M$201M$151M$101M
Total liabilities$427M$356M$335M$332M$327M$265M$262M$210M
Total equity$149M$149M$167M$154M$140M$146M$173M$158M

Implied volatility — last 90 days

20%103%187%270%354% Jun 07 — IV 84% · EM ±11.7%Jun 08 — IV 85% · EM ±11.3%Jun 09 — IV 150% · EM ±18.8%Jun 10 — IV 158% · EM ±18.7%Jun 11 — IV 47% · EM ±5.2%Jun 12 — IV 118% · EM ±12.0%Jun 15 — IV 158% · EM ±11.4%Jun 16 — IV 209% · EM ±12.3%Jun 17 — IV 205% · EM ±8.6%Jun 19 — IV 62% · EM ±13.6%Jun 22 — IV 70% · EM ±14.7%Jun 23 — IV 66% · EM ±13.6%Jun 24 — IV 56% · EM ±11.3%Jun 25 — IV 48% · EM ±9.3%Jun 26 — IV 94% · EM ±18.0%Jun 29 — IV 76% · EM ±13.4%Jun 30 — IV 81% · EM ±13.9%Jul 01 — IV 70% · EM ±11.6%Jul 02 — IV 114% · EM ±18.5%Jul 03 — IV 118% · EM ±18.5%Jul 07 — IV 127% · EM ±16.7%Jul 08 — IV 110% · EM ±13.8%Jul 10 — IV 90% · EM ±9.9%Jul 13 — IV 105% · EM ±8.8%Jul 14 — IV 147% · EM ±10.7%Jul 15 — IV 192% · EM ±11.3%Jul 20 — IV 58% · EM ±13.7%Jul 21 — IV 72% · EM ±16.7%Jul 22 — IV 60% · EM ±13.8%Jul 23 — IV 67% · EM ±15.1%Jul 24 — IV 74% · EM ±16.4%Jul 27 — IV 76% · EM ±15.9%Jul 28 — IV 62% · EM ±12.8%Jul 29 — IV 75% · EM ±15.0%Jul 30 — IV 81% · EM ±15.9%Jul 31 — IV 76% · EM ±14.5%Aug 03 — IV 96% · EM ±17.1%Aug 04 — IV 99% · EM ±17.0%Aug 05 — IV 103% · EM ±17.3%Aug 06 — IV 354% · EM ±57.3%Aug 07 — IV 51% · EM ±8.0%Aug 10 — IV 81% · EM ±11.2%Aug 11 — IV 53% · EM ±7.0%Aug 12 — IV 50% · EM ±6.3%Aug 13 — IV 49% · EM ±5.7%Aug 14 — IV 45% · EM ±4.9%Aug 17 — IV 252% · EM ±21.0%Aug 18 — IV 71% · EM ±5.1%Aug 19 — IV 105% · EM ±6.2%Aug 20 — IV 122% · EM ±5.1%Aug 25 — IV 32% · EM ±6.6%Aug 26 — IV 26% · EM ±5.2%Aug 27 — IV 50% · EM ±9.8%Aug 28 — IV 20% · EM ±3.9%Sep 01 — IV 62% · EM ±10.6%Sep 02 — IV 24% · EM ±3.9%Sep 03 — IV 62% · EM ±10.1%Sep 04 — IV 59% · EM ±9.3%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.